- Pap Smear Tests
- HPV Tests
- LBC Tests
- Others
Cervical Cancer Screening Market size was valued at USD 9,210.4 million in 2023 and is poised to grow at a significant CAGR of 5.4% over 2024-2030. An increase in the prevalence of cervical cancer due to the surge in the global female population is a considerable factor surge the growth of the cervical cancer screening market over the forecast years. Moreover, raising awareness about cancer diseases among people in developed countries, the surge in demand for early-stage disease diagnosis, and favorable reimbursement policies are enhancing the market's revenue.
In addition, the increase in consumption of tobacco and alcohol among the female population, the surge in the prevalence of HPV infection, increase in the incidence of unsafe sex also boost the market over the forecast timeframe. The development of newer tests to diagnose cervical cancer more efficiently the expansion of the business into low-income markets and the high prevalence of cervical cancer countries create some opportunities for marketers. In the cervical cancer screening market, the pap smear tests segment is estimated to lead the global cervical cancer screening market in 2022, in terms of value and volume, owing to increased government funding and insurance coverage.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The global cervical cancer screening market is mainly driven by the increased prevalence of cervical cancer cases and fundraising for cervical cancer screening programs. Changes in the screening criteria, screening rates, lack of awareness about cervical cancer, and adoption of alternate testing procedures will hinder the market growth.
The cervical cancer screening market is projected to expand at a CAGR of 5.4% during the forecast period.
Abbott., Hologic, Inc., QIAGEN, Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated.
North America and Asia-Pacific is the fastest-growing cervical cancer screening market
1.Executive Summary |
2.Global Cervical Cancer Screening Market Introduction |
2.1.Global Cervical Cancer Screening Market - Taxonomy |
2.2.Global Cervical Cancer Screening Market - Definitions |
2.2.1. By Test Type |
2.2.2. By Region |
3.Global Cervical Cancer Screening Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Cervical Cancer Screening Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Cervical Cancer Screening Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Pap Smear Tests |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. HPV Tests |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. LBC Tests |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Cervical Cancer Screening Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. North America |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Europe |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Asia Pacific (APAC) |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Middle East and Africa (MEA) |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Latin America |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.North America Cervical Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.1.1.Pap Smear Tests |
7.1.2.HPV Tests |
7.1.3.LBC Tests |
7.1.4.Others |
7.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.2.1.United States of America (USA) |
7.2.2.Canada |
8.Europe Cervical Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Pap Smear Tests |
8.1.2.HPV Tests |
8.1.3.LBC Tests |
8.1.4.Others |
8.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Germany |
8.2.2.France |
8.2.3.Italy |
8.2.4.United Kingdom (UK) |
8.2.5.Spain |
9.Asia Pacific (APAC) Cervical Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Pap Smear Tests |
9.1.2.HPV Tests |
9.1.3.LBC Tests |
9.1.4.Others |
9.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.China |
9.2.2.India |
9.2.3.Australia and New Zealand (ANZ) |
9.2.4.Japan |
9.2.5.Rest of APAC |
10.Middle East and Africa (MEA) Cervical Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Pap Smear Tests |
10.1.2.HPV Tests |
10.1.3.LBC Tests |
10.1.4.Others |
10.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.GCC Countries |
10.2.2.South Africa |
10.2.3.Rest of MEA |
11.Latin America Cervical Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Pap Smear Tests |
11.1.2.HPV Tests |
11.1.3.LBC Tests |
11.1.4.Others |
11.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Brazil |
11.2.2.Mexico |
11.2.3.Rest of LA |
12. Competition Landscape |
12.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
12.2.1.Hologic, Inc. |
12.2.2.Abbott, |
12.2.3.QIAGEN |
12.2.4.Hoffmann-La Roche Ltd |
12.2.5.Quest Diagnostics Incorporated. |
12.2.6.Becton, Dickinson, and Company |
12.2.7.Cooper Surgical Inc., |
12.2.8.Arbor Vita Corporation, |
13. Research Methodology |
14. Appendix and Abbreviations |